ArticleCureus2024
Tumor Lysis Syndrome in a 30-Year-Old Male With Metastatic Seminoma: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 30-year-old Hispanic male was admitted to the medicine service for a growing left testicular and pan-abdominal mass. His prior medical and surgical history was unremarkable. CT imaging showed a retroperitoneal and intraperitoneal mass. Testicular ultrasound revealed an 11.3 cm left scrotal mass. The biopsy of both masses was positive for metastatic seminoma. The patient underwent a left radical orchiectomy and was initiated on five cycles of bleomycin, etoposide, and cisplatin. Prior to the initiation of chemotherapy, the patient met the Cairo-Bishop criteria for tumor lysis syndrome (TLS) with several electrolyte derangements. He did not have clinical symptoms secondary to TLS and no EKG changes were observed. The patient was initiated on IV normal saline as well as allopurinol, which stabilized both the uric acid and potassium levels. Patients diagnosed with solid tumor malignancy should be monitored for TLS, even prior to initiation of chemotherapy, in the setting of extensive tumor burden, as the consequences of this syndrome can be rapidly fatal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.